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Abstract
Background: The World Health Organization recommends insecticidal bednets and intermittent preventive treatment to
reduce malaria in pregnancy. Longitudinal data of malaria prevalence and pregnancy outcomes are valuable in gauging the
impact of these antimalarial interventions.
Methodology/Principal Findings: We recruited 8,131 women delivering in a single Malawian hospital over 9 years. We
recorded demographic data, antenatal prescription of intermittent preventive therapy during pregnancy with sulfadoxine-
pyrimethamine and bed net use, and examined finger-prick blood for malaria parasites and hemoglobin concentration. In
4,712 women, we examined placental blood for malaria parasites and recorded the infant’s birth weight. Peripheral and
placental parasitemia prevalence declined from 23.5% to 5.0% and from 25.2% to 6.8% respectively. Smaller declines in
prevalence of low birth weight and anemia were observed. Coverage of intermittent preventive treatment and bednets
increased. Number of sulfadoxine-pyrimethamine doses received correlated inversely with placental parasitemia (Odds Ratio
(95% CI): 0.79 (0.68, 0.91)), maternal anemia (0.81, (0.73, 0.90)) and low birth weight from 1997–2001 (0.63 (0.53, 0.75)), but
not from 2002–2006. Bednet use protected from peripheral parasitemia (0.47, (0.37, 0.60)) and placental parasitemia (0.41,
(0.31, 0.54)) and low birth weight (0.75 (0.59, 0.95)) but not anemia throughout the study. Compared to women without
nets who did not receive 2-dose sulfadoxine-pyrimethamine, women using nets and receiving 2-dose sulfadoxine-
pyrimethamine were less likely to have parasitemia or low birth weight babies. Women receiving 2-dose sulfadoxine-
pyrimethamine alone had little evidence of protection whereas bednets alone gave intermediate protection.
Conclusions/Significance: Increased bednet coverage explains changes in parasitemia and birth weight among pregnant
women better than sulfadoxine-pyrimethamine use. High bed net coverage, and sulfadoxine-pyrimethamine resistance,
may be contributing to its apparent loss of effectiveness.
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Introduction
Malaria in pregnancy is a major public health problem in sub-
Saharan Africa, causing significant maternal and infant morbidity
and mortality [1,2,3,4]. Recent decreases in pediatric malaria
infection [5,6] and malaria burden [7] may be due to improved
access to effective treatments including artemisinin combination
therapies, or to increased coverage with insecticide-treated nets
(ITN). Globally, the World Malaria Report shows recent declines in
malaria cases and deaths [8,9], possibly reflecting a combination of
real progress and improved ascertainment of correct information.
In 1993 Malawi introduced intermittent preventive treatment
during pregnancy (IPTp), comprising two treatment doses of
sulfadoxine-pyrimethamine (SP) for all pregnant women at
Antenatal Clinics. SP has been shown to protect pregnant women
from malaria [10], but the spread of SP resistant P. falciparum
[11,12,13] raises the importance of investigating the ongoing
effectiveness of SP IPTp. Provision of ITNs through health
facilities, communities and the private sector has increased
population coverage in Malawi [8], but the impact of increased
coverage on malaria in pregnancy has not been widely studied.
Using longitudinal data collected between 1997 and 2006 in
Blantyre, Malawi, we have investigated the changes in malaria
prevalence among pregnant women and their pregnancy out-
comes in a single hospital, and how the changes in these outcomes
are associated with SP IPTp and bed net coverage.
Results
Summary of study population
Between 1997 and 2006, we recruited 8131 pregnant women.
Of these women, 4031 were primigravid (49.6%), 4088 were
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women (0.1%). The percentage of primigravid women varied
between 39.5% in 1997 and 54.0% in 1999; 48.8% of women
delivering in 1997–2001 and 50.0% of women delivering from
2002 onwards were primigravidae. Overall, 796 out of 7671
women (10.4%) had peripheral parasitemia, 667 out of 4831
women (13.8%) had placental parasitemia, 2278 out of 7964
women (28.6%) were anemic and 555 out of 4715 (11.8%)
newborn infants were LBW.
For women who did not deliver while the study team was
present, we were not able to collect information on placental
malaria infection or birth weight. However, the characteristics of
these women were similar to those of women with delivery data
available (Table 1).
Trends in malaria prevalence and malaria related
outcomes from 1997 to 2006
Over the study period there were declines in prevalence of
peripheral and placental parasitemia, maternal anemia and LBW
(Figure 1). The prevalence of peripheral parasitemia dropped from
23.5% during 1997-8 to 5.0% during 2005-6. Prevalence of
placental malaria decreased from 25.2% during 1997-8 to 6.8%
during 2005-6.
Among malaria infected women, between 1997-8 and 2005-6
peripheral parasite densities among malaria infected women
increased from a geometric mean of 568/ml to 1302/ml, and
placental parasite density increased from 1091/ml to 1737/ml
(Figure 2). Over the same period, the prevalence of maternal
anemia decreased from 37.0% to 24.5%; the average hemoglobin
concentration increased from 11.5 g/dl to 12.1 g/dl; the preva-
lence of LBW decreased from 14.1% to 8.9%; and the mean birth
weight increased from 2927 g to 3024 g (Figure 1).
There were no significant changes in rainfall patterns over the
study period (Figure 1).
After adjusting for gravidity, season and local rainfall, we
observed a strong association between year of enrollment and
prevalenceofmalaria and associated pregnancyoutcomes(Table 2).
The odds of peripheral parasitemia declined by 22% each year,
while the odds of placental parasitemia, maternal anemia and LBW
decreased by 19%, 6% and 6% per year, respectively.
SP IPTp coverage from 1997 to 2006
The percentage of women receiving at least one dose of SP
IPTp (documented on their ANC cards) increased from 77.0% in
1997 to 95.3% in 2004. For the second documented dose, the
coverage increased from 27.0% in 1997 to 77.8% in 2004.
Coverage decreased in 2005 and 2006 (Figure 3). The number of
SP doses recorded, and the number of doses reported to have been
taken, were highly correlated (r=0.84).
Effect of SP IPTp on prevention of malaria and
subsequent outcomes from 1997 to 2006
We previously observed an inverse relationship between
number of doses of SP IPTp prescribed and prevalence of malaria
infection, anemia and LBW [14]. P. falciparum parasites resistant to
SP have become highly prevalent in Malawi [15], so we explored
whether SP effectiveness has changed over time. After adjusting
for season of enrollment, gravidity and rainfall, the relative
reduction in the odds for placental parasitemia, hemoglobin and
birth weight were modified by year of enrollment. Among women
enrolled from 1997–2001, the number of SP IPTp doses was
associated with protection against placental parasitemia, maternal
anemia and LBW, and with increases in mean maternal
hemoglobin levels and birth weights, whereas from 2002 onwards,
these protective associations were not found (Table 3).
Bed net coverage in protection against malaria in
pregnancy
Information on bed net coverage was not recorded prior to
1999, leaving data available for analyses from 6064 pregnancies.
Bed net coverage increased substantially from 14.4% in 1999 to
60.5% in 2006 (Figure 3), and was associated with a decreased
odds for peripheral or placental parasitemia and LBW, but not
anemia (Table 4). Infants’ birth weight was 47 g higher in women
using bed nets than in non-users (Table 4). The protective effect of
bed nets was not changed between 1999–2002 and 2003–2006
(data not shown).
Among women receiving at least two doses of SP IPTp and
using a bed net, the prevalence of peripheral malaria, placental
malaria and LBW was significantly decreased in comparison to
women without bed nets and receiving one, or no, doses of SP
IPTp. Hemoglobin levels were marginally higher in the women
who had used bed nets and received optimal dosing of SP IPTp
compared with women receiving sub-optimal SP IPTp and not
using a bed net. Women with bed nets but with #1 dose of SP
IPTp showed intermediate levels of protection, whereas women
receiving $2 SP IPTp doses without nets were not significantly
protected from malaria or its consequences (Table 5).
Table 1. Characteristics of women with and without delivery data available.
Delivery data No delivery data
Primigravidae 2254/4712 (47.69%) 1777/3407 (52.36%)
Rainfall over 6 months prior to delivery (mm)
a 585 (574, 596) 572 (559, 585)
Doses of SP received at ANC
0 611/4535 (13.5%) 408/3304 (12.3%)
1 1617/4535 (35.7%) 919/3304 (27.8%)
2 1533/4535 (33.8%) 1183/3304 (35.8%)
3+ 774/4535 (17.1%) 794/3304 (24.0%)
Hemoglobin (g/dl)
b 11.961.9 11.861.8
Anemia 1295/4593 (28.2%) 983/3371 (29.2%)
aGeometric mean and 95% CI.
bMean 6 S.
doi:10.1371/journal.pone.0012012.t001
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In this study, we demonstrate marked changes in prevalence of
malaria parasitemia among pregnant Malawian women attending
a tertiary hospital for delivery over a 10-year period. These
changes were associated with concomitant decreases in prevalence
of maternal anemia and LBW, important indicators of maternal
malaria morbidity. This result is in keeping with declines in
malaria illness in young children from East and West Africa, over
similar time frames [5,6].
Together with the decreased prevalence of malaria infection,
maternal anemia and LBW, we observed increased coverage with
SP IPTp and with bed nets. In other studies in subsets of
participating women, we found that the proportion of bed nets
that were ITNs increased from 69% in 1997–1999 to 89% in
2001–2006 (SJR, unpublished). Increased coverage with IPTp and
ITNs appears to be the likeliest explanation for the changes we
have documented. While SP primarily protects the individual
woman, ITNs may both protect the individual and (through their
mosquito-killing activity) have community-wide effects.
Earlier studies showed that SP use was associated with
decreased prevalence of placental malaria, maternal anemia and
LBW [14], but coverage was low [14,16], leading to initiatives to
simplify policy and improve access to SP [17]. These resulted in a
significant increase in IPTp coverage rates; the reasons underlying
recent declines are not known, but may include turnover of ANC
staff and unmet needs for ongoing training, and/or logistic
difficulties in drug procurement and delivery. Identifying the
obstacles to maintaining IPTp coverage at high levels is an
important research priority.
The relationship between IPT use and parasitemia, anemia and
low birth weight changed over time. Between 1997 and 2001 SP
IPTp was associated with decreased placental malaria, maternal
anemia and LBW, but these associations were lost from 2002–
2006. We considered two possible explanations: increased parasite
resistance to SP, and masking of a protective effect of SP by
increased ITN coverage or by declining malaria prevalence and
malaria-attributable morbidity, for other external reasons. Parasite
resistance may compromise the efficacy of SP as treatment for
malaria [13,18]. Studies have demonstrated a high prevalence of
SP-resistant P. falciparum in Malawi [12,15,19] associated with SP
treatment failure in children and pregnant women [13,20].
Published data from children and pregnant women in Blantyre
over the study period show that ‘‘quintuple’’ mutant parasites with
two mutations in the dihydropteroate synthase (dhps) gene and
three dihydrofolate reductase (dhfr) mutations were highly
prevalent in Blantyre over the study period [19,21], but mutations
associated with higher level SP resistance such as dhps 581[15] or
dhfr 164 [19] remained rare. It appears unlikely that the loss of SP
effectiveness can be ascribed solely to increasing drug resistance.
Increasing bed net coverage (from 14.4% to 60.5%, with
increasing proportions of these ITNs) might make SP appear less
effective. We found that bed net use was constantly associated with
protection against malaria infection and LBW, as described for
Figure 2. Summary of parasite density among malaria infected women from 1999 to 2006. Lines indicate geometric mean parasite
density and error bars indicate 95% CI.
doi:10.1371/journal.pone.0012012.g002
Figure 1. Prevalence of parasitemia, anemia and LBW and monthly rainfall in Chichiri from 1997 to 2006. Lines indicate prevalence and
error bars indicate 95% CI, bars indicate accumulated monthly rainfall.
doi:10.1371/journal.pone.0012012.g001
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increase birth weight, and SP IPTp decreases severe maternal
anemia [10,23], but it is less clear whether the two interventions
have additive benefits [22,24]. When we compared women using
bed nets and SP IPTp singly and in combination to those using
neither, women receiving both interventions had a lower
prevalence of peripheral parasitemia, placental parasitemia and
LBW than other women. It may be that administration of SP IPTp
was synergistic with bed net use in our population; alternatively,
women receiving both interventions may be at lower risk of
malaria in pregnancy or its complications owing to differences in
variables that we did not measure, such as education or
socioeconomic status. We were limited in our ability to examine
fully the effects of contemporaneous changes in SP use, bed net use
and malaria transmission by our sample size; larger studies from
areas with differing rates of SP and ITN use would be needed to
resolve this question.
As previously reported [23,25], we found that bed nets were not
protective against anemia, suggesting that the decrease in anemia
may have occurred through other mechanisms, or possibly reflects
a community-wide change in the impact of malaria on anemia,
rather that a direct protective effect of bed nets. This is in contrast
to observations in children from Blantyre over a similar period, in
whom sleeping under an ITN was associated with significantly
higher hemoglobin levels [26].
Our data collection ended in 2006, and in 2007 Malawi
adopted artemether-lumefantrine as first line treatment for malaria
in children [27], retaining SP for IPTp. Withdrawal of
chloroquine first line treatment in Malawi in 1993 was followed
by subsequent re-emergence of chloroquine sensitive parasites
[28]. Whether withdrawal of SP for treatment will lead to re-
emergence of SP-sensitive parasites is unknown, but the wide-
spread use of other antifolates such as cotrimoxazole may inhibit
any such process. In South East Asia, parasite genetic markers of
sulfadoxine resistance remain at high levels long after SP was
replaced in Cambodian antimalarial treatment policy[29].
Changes in rainfall may cause fluctuations in malaria
transmission and in the prevalence of parasitemia, but these
seemed not to explain the large changes in malaria observed. HIV
increases susceptibility to malaria [30], but rates of HIV
seroprevalence among women attending our hospital were
relatively constant [31,32], suggesting that changing HIV
epidemiology is also not responsible. We know of no changes in
hospital use or other host factors to explain the changes seen; there
are no data on entomological inoculation rates for Blantyre over
the study period. The proportion of malaria-susceptible primi-
gravid women did not change consistently over the time of the
study.
In areas of high malaria transmission, pregnancy-specific
immunity develops over the first one or two pregnancies. In
children, interruption of malaria transmission leads to decreased
specific immunity and increased susceptibility to severe disease
[33,34], and it will be important to determine whether the
declining prevalence of malaria in pregnancy leads to decreased
pregnancy-specific immunity, and an increased risk of severe
disease among those women still being infected. In our study,
parasite prevalence fell from levels consistent with stable
transmission to levels comparable to those reported from areas
of low or unstable transmission [4]. This was associated with an
increase in the mean parasite density amongst infected women
consistent with weakening immune regulation of parasite density.
We did not record symptomatology in our participants, but
improved control of malaria in pregnancy may result in increasing
Table 2. Changes in prevalence of parasitemia, anemia and LBW due to time, rainfall, gravidity and season
a.
Peripheral parasitemia
(n=7671)
Placental parasitemia
(n=4831)
Maternal anemia
(n=7964)
LBW
(n=4715)
OR
(95% CI) P-value
OR
(95% CI) P-value
OR
(95% CI) P-value
OR
(95% CI) P-value
Each year increase 0.78
(0.76, 0.80)
,0.001 0.81
(0.79, 0.84)
,0.001 0.94
(0.93, 0.96)
,0.001 0.94
(0.91, 0.97)
,0.001
Two-fold increase in rainfall
(mm)
b
1.03
(0.99, 1.09)
0.13 1.08
(1.02, 1.14)
0.01 0.97
(0.94, 1.00)
0.09 1.15
(1.07, 1.22)
,0.001
Multigravidae 0.81
(0.70, 0.94)
0.01 0.65
(0.55, 0.77)
,0.001 1.15
(1.04, 1.26)
0.01 0.53
(0.44, 0.64)
,0.001
Dry season 0.59
(0.50, 0.68)
,0.001 0.51
(0.43, 0.61)
,0.001 0.75
(0.68, 0.82)
,0.001 0.83
(0.70, 1.00)
0.05
NOTE. –LBW = Low Birth Weight; OR = Odds Ratio; CI = Confidence Interval;
aMutually adjusted for year of enrollment, rainfall, gravidity and season of enrollment;
bTotal rainfall over 6 months prior to delivery date.
doi:10.1371/journal.pone.0012012.t002
Figure 3. SP IPTp and ITN coverage between 1997 and 2006.
Percentage of women receiving the first dose of IPTp (dashed line),
second dose of IPTp (dotted line), and women reporting bednet use
(solid line). Error bars indicate 95% CI.
doi:10.1371/journal.pone.0012012.g003
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severe or symptomatic disease.
This study does have some potential limitations. Although we
recruited more than 8,000 women, these women only count for
less than 10% of the total deliveries during the study period.
Moreover, the number of study participants included each year
varied because of changing availability of staff to recruit study
participants; although logistical issues associated with starting a
separate study [35,36] meant that we had limited recruitment in
2001, decreasing the precision of our measurements for that year,
the findings from this smaller sample are consistent with overall
annual trends observed. Because the study team was only present
during normal working hours, we could not collect delivery data
from women who delivered out of hours. This missing delivery
data could potentially have biased our findings, but we believe this
is unlikely, because characteristics of women with and without
delivery data were very similar (Table 1). We could not uniquely
identify each woman, and women could have been recruited in
successive pregnancies leading to potential within-person correla-
tions of outcomes among these women. However, it is unlikely
with such a large sample that multiple enrolments would
significantly affect our conclusions regarding SP IPTp and bed
net use (p-value ,0.001 for most analyses).
A recent paper critiqued facility-based surveys as tools to
evaluate changing malaria epidemiology [37]. Because we used
hospital-based convenience sampling we cannot claim that our
data are representative of changing epidemiology in the whole
community, but by using the one facility, and the same approach
to measurement of all variables throughout the study, we believe
changes in measures over time are robust. We documented ANC
SP prescription from ANC cards, but also noted a very strong
correlation (r=0.84) between number of SP doses recorded on the
ANC cards and doses women self-reported as taking during
pregnancy from any source, and only 1.9% of women reported
taking fewer doses of SP than were recorded on ANC cards.
Because Malawian policy encourages primigravidae and women at
risk to deliver at hospital and other women to deliver at health
centers, relatively high proportions of primigravidae at higher risk
of malaria were recruited, which could lead to an over estimate of
the prevalence of malaria. In a separate study of HIV-malaria
interactions in pregnancy, we performed malaria microscopy on
3825 different women admitted to the antenatal and delivery
wards of the same hospital near term. Nine percent had peripheral
Table 3. Association between doses of SP IPTp treatment and prevalence of parasitemia, anemia and LBW.
Overall
a
Enrolled before
1
st Jan 2002
b
Enrolled after
1
st Jan 2002
b
OR
c (95% CI) P-value OR
c (95% CI) OR
c (95% CI) P-value
e
Peripheral parasitemia
(n=7671)
0.91
(0.84, 1.00)
0.050 0.96
(0.84, 1.09)
0.95
(0.84, 1.07)
0.941
Placental parasitemia
(n=4831)
0.85
(0.77, 0.94)
0.002 0.79
(0.68, 0.91)
0.95
(0.82, 1.10)
0.062
Maternal anemia
(n=7964)
0.96
(0.91, 1.01)
0.134 0.81
(0.73, 0.90)
1.00
(0.94, 1.07)
0.001
LBW
(n=4715)
0.79
(0.72, 0.88)
,0.001 0.63
(0.53, 0.75)
0.90
(0.78, 1.03)
0.002
b
d (95% CI) P-value b
d (95% CI) b
d (95% CI) P-value
e
Hemoglobin (g/dl)
(n=7964)
0.03
(20.02, 0.07)
0.216 0.16
(0.06, 0.26)
0.01
(20.04, 0.07)
0.007
Birth weight (g)
(n=4715)
36.5
(21.0, 51.9)
,0.001 74.9
(48.2, 101.6)
15.2
(24.5, 34.8)
,0.001
NOTE. –SP = Sulfadoxine-Pyrimethamine; IPTp= Intermittent Preventive Therapy OR = Odds Ratio; CI = Confidence Interval; LBW = Low Birth Weight.
aAdjusted for year and season of delivery, gravidity and 6 months rainfall prior to delivery;
bAdjusted for season of delivery, gravidity and 6 months rainfall prior to delivery;
cOdds Ratio for each additional dose of SP IPTp prescribed through antenatal clinics, up to 3 doses;
dPredicted mean change for each additional dose of SP IPTp prescribed through antenatal clinics, up to 3 doses;
eFrom likelihood ratio test investigating interaction between SP IPTp treatment and year of enrollment (before/after 1
st 2002).
doi:10.1371/journal.pone.0012012.t003
Table 4. Association between bednet usage and prevalence
of parasitemia, anemia and LBW
a.
Bednet use
OR
b (95% CI) P-value
Peripheral parasitemia
(n=5665)
0.47 (0.37, 0.60) ,0.001
Placental parasitemia
(n=3574)
0.41 (0.31, 0.54) ,0.001
Maternal anemia
(n=5925)
0.94 (0.83, 1.06) 0. 29
LBW
(n=3496)
0.75 (0.59, 0.95) 0.02
b
c (95% CI) P-value
Hemoglobin (g/dl)
(n=5925)
0.07 (20.02, 0.17) 0.14
Birth weight (g)
(n=3496)
46.8 (13.8, 79.9) 0.005
NOTE. –LBW = Low Birth Weight; OR = Odds Ratio; CI = Confidence Interval;
aAdjusted for year and season of delivery, gravidity and 6 months rainfall prior
to delivery.
bOdds Ratio for women using bednet compared to women who did not use
bednet.
cPredicted mean change for women using bednet compared to women who
did not use bednet.
doi:10.1371/journal.pone.0012012.t004
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parasite rate we observed, of 10.4%, and to the rate we observed
in women recruited to the present study over the same period from
2001–2004, of 6.7%. It is therefore unlikely that our sampling has
systematically biased us to collect women with a particularly high
prevalence of malaria infection. Because of the demonstrated
benefit of IPTp and ITNs, observational studies are the only
ethical way to study the relationship between intervention use and
outcomes.
It is not clear how representative our data are of Malawi as a
whole,orofmalaria-endemiccountriesinsub-Saharan Africa.Most
women in our study were urban residents, and may have self-
selected to deliver in hospital. Local programmes to improve uptake
of SP IPTp [17] or ITNs may have a geographically restricted
impact. Changes in malaria prevalence may vary across different
regions of a country [38]. Similar longitudinal studies, in a mix of
urban and rural areas in Malawi and in other malaria-endemic
countries should be undertaken. Such information will be valuable
to document possible changes in malaria epidemiology follow-
ing increased implementation of malaria control and treatment
strategies including ITNs, indoor residual spraying and ACTs.
In conclusion, malaria infection declined significantly among
pregnant women delivering in Blantyre between 1997 and 2006,
and this was accompanied by declines in prevalence of anemia and
LBW deliveries. Mean birth weights increased by 97 g, a change
of similar magnitude to the reported benefits of effective malaria
chemoprophylaxis or IPTp in pregnancy [10], and greater than
that reported with use of ITNs [23]. We postulate that differences
in the use, and protective efficacy, of IPT or bed nets might
explain these changes. Using part of this data set we previously
reported that SP use was associated with protection against
parasitemia, LBW and anaemia [14], but this association
disappeared over the course of the present study. Whilst it is not
clear from our data that increasing SP resistance explains this
change, there is nevertheless an urgent need to find alternatives to
SP for use in IPTp. Bed net use was strongly associated with
decreased malaria infection and improved birth weight, underlin-
ing the importance of bed nets as a malaria control tool.
Importantly, our data suggest that, among women with good access
to health facilities, high rates of coverage with IPTp and ITNs can be
achieved, and that these may be associated with significant reductions
in the burden of malaria in pregnancy. With an increasing focus on
reducing the malaria burden, it will be of great value to discover
whether similar reductions can be obtained in other settings, through
scale up of these recommended interventions to WHO’s target levels.
Materials and Methods
Ethics Statement
Ethics approval for this study was given by the Malawi Health
Sciences Research Committee and the Research Ethics Commit-
tee of the College of Medicine, University of Malawi.
Study site and population
We recruited women delivering in the maternity unit of Queen
Elizabeth Central Hospital in Blantyre, Malawi, an urban hospital
hosting 15,000 deliveries annually. Malaria transmission in
Blantyre is perennial with a seasonal peak during the rainy season.
Primigravidae and at-risk pregnant women are specifically
encouraged to deliver in the hospital.
Data collection
We recruited study participants between July 1997 and August
2006. Data from 1644 women delivering between July 1997 and
November 1999 were included in a previous publication [14].
Participants were selected under the same criteria as previously
described [14]. Women attending the maternity unit for delivery
gave verbal consent for participation. Those who were not in
active labor or were unlikely to deliver during working hours were
not recruited.
We recorded participants’ demographic and clinical data and
noted the number of doses of SP prescribed at Antenatal Clinics
(ANC) as shown on ANC cards. We separately asked women the
number of courses of SP they had received during pregnancy. We
used finger prick blood samples to prepare thick blood films for
immediate microscopy for maternal malaria parasitemia and to
Table 5. Association between full dose SP IPTp (more than 2 doses) and bednets and prevalence of malaria, anemia and LBW
a.
Bednet only SP only Bednet and SP
OR (95% CI)
b P-value OR (95% CI)
b P-value OR (95% CI)
b P-value
Peripheral parasitemia 0.54
(0.38, 0.79)
0.001 0.87
(0.67, 1.13)
0.31 0.38
(0.27, 0.53)
,0.001
Placental parasitemia 0.52
(0.35, 0.75)
0.001 0.98
(0.75, 1.28)
0.90 0.33
(0.23, 0.49)
,0.001
Maternal anemia 0.86
(0.70, 1.04)
0.13 0.90
(0.77, 1.06)
0.20 0.88
(0.75, 1.05)
0.17
LBW 0.59
(0.30,1.16)
0.13 0.77
(0.59, 1.03)
0.08 0.57
(0.41, 0.79)
0.001
b (95% CI)
c P-value b
c (95% CI)
c P-value b (95% CI)
c P-value
Hemoglobin (g/dl) 0.15
(20.01, 0.31)
0.06 0.11
(20.02, 0.24)
0.10 0.14
(0.00, 0.27)
0.05
Birth weight (g) 66.8
(16.5, 117.2)
0.009 55.5
(14.1, 96.8)
0.009 85.0
(40.4, 129.6)
,0.001
NOTE. –SP = Sulfadoxine-Pyrimethamine; IPTp= Intermittent Preventive Therapy OR = Odds Ratio; CI = Confidence Interval; LBW = Low Birth Weight.
aAdjusted for season of delivery, gravidity and 6 months rainfall prior to delivery.
bOdds Ratio relative to women receiving less than 2 doses of SP IPTp and no bed net.
cPredicted mean change from women receiving less than 2 doses of SP IPTp and no bed net.
doi:10.1371/journal.pone.0012012.t005
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(HemoCueAB, Angelholm, Sweden). When women delivered in
the presence of the study team, we pricked the cleaned maternal
placental surface with a grooved stylet (which collected a droplet of
blood in its groove) and used this droplet to make a thick blood
film. All thick blood films were examined twice by trained
microscopists, counting at least 200 white blood cells, and parasite
counts were recorded as the average of the two readings. If results
disagreed (positive vs negative, or marked difference in density), a
third independent reading was performed, and the two closest
results were averaged. An assumed white cell count of 6000/ml was
used to convert parasite counts to densities per ml. While study
microscopists changed over the study period, the procedures were
consistent throughout.
We collected information on bed net use from 1999 to 2006
except for 2001 by asking whether the women were usually
sleeping under a bed net. Information on whether the net was
insecticide impregnated, or when, was not routinely available.
From the Bureau of Meteorology, Malawi, we obtained monthly
rainfall data for Chichiri, Blantyre between 1997 and 2006.
Data analysis
We classified participants as primigravidae (first pregnancy) or
multigravidae (second and subsequent pregnancy). Doses of SP
IPTp were classified as no SP treatment, 1 dose, 2 doses, or $3
doses. For some analyses, we divided year of enrollment into early
(1997–2001) and late (2002–2006). Bed net usage was coded as
whether or not the woman usually slept under a bed net. We
defined anemia as hemoglobin concentration ,11 g/dl and low
birth weight (LBW) as infant’s birth weight ,2500 g. Seasons were
classified as rainy (November to April) and non-rainy (May to
October) based on the delivery date. Monthly rainfall data were
summed over the 6 months prior to delivery to represent rainfall
exposure during the 2
nd and 3
rd trimesters. Cumulative rainfall
exposure was not normally distributed, and, therefore, the variable
was log2 transformed before analysis.
The exposure variables of interest were SP IPTp (0, 1, 2 or $3
doses) and bed net use. Outcome variables were peripheral
parasitemia (detection of parasites in peripheral blood), placental
parasitemia (detection of parasites in placental blood), maternal
hemoglobin concentration at delivery and anemia, infant’s birth
weight and LBW. Maternal gravidity, season of enrollment and
rainfall were considered as confounding factors. We performed
multivariable logistic regression, adjusting for the confounders
described above, to investigate how the prevalence of maternal
peripheral parasitemia, placental parasitemia, maternal anemia
and LBW changed over time and how these outcomes varied with
SP IPTp and bed net use. We also analyzed the impact of SP IPTp
and bed net use on maternal hemoglobin level and birth weight
using multiple linear regression. To explore whether the SP IPTp
protection effect was modified over the study period, an
interaction term between SP IPTp and year of enrolment (before
versus after 1
st January 2002, the mid-point of study period) was
fitted, and tested using the likelihood ratio test. To investigate the
combined effect of SP IPTp and bed net use we included a
variable with the following categories: $2 doses of SP IPTp and
bed net use; $2 doses of SP IPTp only; sub-optimal (#1 dose) SP
IPTp and bed net use; and no bed net and sub-optimal SP IPTp
during pregnancy. All statistical analyses were performed using
Stata 9.2 (StataCorp, College Station, TX, USA).
Acknowledgments
We thank for the nurses and technicians in Queen Elizabeth Central
Hospital, Blantyre, Malawi for carrying out the clinical study, and
especially thank the pregnant women who participated.
Author Contributions
Conceived and designed the experiments: MEM SJR. Performed the
experiments: EC. Analyzed the data: GF JAS SJR. Wrote the paper: GF
JAS SJR.
References
1. Taha Tel T, Gray RH, Mohamedani AA (1993) Malaria and low birth weight in
central Sudan. Am J Epidemiol 138: 318–325.
2. Rogerson SJ, van den Broek NR, Chaluluka E, Qongwane C, Mhango CG,
et al. (2000) Malaria and anemia in antenatal women in Blantyre, Malawi: a
twelve-month survey. Am J Trop Med Hyg 62: 335–340.
3. Luxemburger C, McGready R, Kham A, Morison L, Cho T, et al. (2001) Effects
of malaria during pregnancy on infant mortality in an area of low malaria
transmission. Am J Epidemiol 154: 459–465.
4. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al. (2007)
Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93–104.
5. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, et al. (2008)
Changes in malaria indices between 1999 and 2007 in The Gambia: a
retrospective analysis. Lancet 372: 1545–1554.
6. O’Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, et al. (2008) Effect of
a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet
372: 1555–1562.
7. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, et al. (2007) Impact
of artemisinin-based combination therapy and insecticide-treated nets on
malaria burden in Zanzibar. PLoS Med 4: e309.
8. World Health Organization (2005) World malaria report 2005. Geneva,
Switzerland: World Health Organization. v. p.
9. World Health Organization (2008) World malaria report 2008. Geneva,
Switzerland: World Health Organization. v. p.
10. Garner P, Gulmezoglu AM (2006) Drugs for preventing malaria in pregnant
women. Cochrane Database Syst Rev. CD000169.
11. ter Kuile FO, van Eijk AM, Filler SJ (2007) Effect of sulfadoxine-pyrimethamine
resistance on the efficacy of intermittent preventive therapy for malaria control
during pregnancy: a systematic review. JAMA 297: 2603–2616.
12. Nkhoma S, Molyneux M, Ward S (2007) Molecular surveillance for drug-
resistant Plasmodium falciparum malaria in Malawi. Acta Trop 102: 138–142.
13. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, et al.
(2004) Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncompli-
cated falciparum malaria in Malawi after 10 years as first line treatment: five
year prospective study. BMJ 328: 545.
14. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, et al. (2000)
Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against
malaria morbidity in Blantyre, Malawi, in 1997-1999. Transactions of the
Royal Society of Tropical Medicine and Hygiene 94: 549–553.
15. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC,
et al. (2009) Competitive facilitation of drug-resistant Plasmodium falciparum
malaria parasites in pregnant women who receive preventive treatment. Proc
Natl Acad Sci U S A 106: 9027–9032.
16. Holtz TH, Kachur SP, Roberts JM, Marum LH, Mkandala C, et al. (2004) Use
of antenatal care services and intermittent preventive treatment for malaria
among pregnant women in Blantyre District, Malawi. Trop Med Int Health 9:
77–82.
17. Ashwood-Smith H, Coombes Y, Kaimila N, Bokosi M, K L (2002) Availability
and use of sulphadoxine-pyrimethamine (SP) in pregnancy in Blantyre District:
A Safe Motherhood and BIMI Joint Survey. Malawi Medical Journal 14: 8–11.
18. Nzila AM, Nduati E, Mberu EK, Hopkins Sibley C, Monks SA, et al. (2000)
Molecular evidence of greater selective pressure for drug resistance exerted by
the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the
shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.
J Infect Dis 181: 2023–2028.
19. Alker AP, Mwapasa V, Purfield A, Rogerson SJ, Molyneux ME, et al. (2005)
Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil
resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrob
Agents Chemother 49: 3919–3921.
20. Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Alker AP, et al. (2007) A
randomized controlled pilot trial of azithromycin or artesunate added to
sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS
ONE 2: e1166.
21. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, et al.
(2002) Molecular markers for failure of sulfadoxine-pyrimethamine and
Prevention against Malaria
PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12012chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect
Dis 185: 380–388.
22. Menendez C, Bardaji A, Sigauque B, Romagosa C, Sanz S, et al. (2008) A
randomized placebo-controlled trial of intermittent preventive treatment in
pregnant women in the context of insecticide treated nets delivered through the
antenatal clinic. PLoS ONE 3: e1934.
23. Gamble C, Ekwaru JP, ter Kuile FO (2006) Insecticide-treated nets for
preventing malaria in pregnancy. Cochrane Database Syst Rev. CD003755.
24. Njagi JK, Magnussen P, Estambale B, Ouma J, Mugo B (2003) Prevention of
anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-
pyrimethamine in a highly malarious area of Kenya: a randomized controlled
trial. Trans R Soc Trop Med Hyg 97: 277–282.
25. Lengeler C (2004) Insecticide-treated bed nets and curtains for preventing
malaria. Cochrane Database Syst Rev. CD000363.
26. Mathanga DP, Campbell CH, Taylor TE, Barlow R, Wilson ML (2006) Socially
marketed insecticide-treated nets effectively reduce Plasmodium infection and
anaemia among children in urban Malawi. Trop Med Int Health 11:
1367–1374.
27. Malenga G, Wirima J, Kazembe P, Nyasulu Y, Mbvundula M, et al. (2009)
Developing national treatment policy for falciparum malaria in Africa: Malawi
experience. Trans R Soc Trop Med Hyg 103 Suppl 1: S15–18.
28. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, et al.
(2006) Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355:
1959–1966.
29. Vinayak S, Alam MT, Mixson-Hayden T, McCollum AM, Sem R, et al. (2010)
Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS
Pathog 6: e1000830.
30. ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, et al.
(2004) The burden of co-infection with human immunodeficiency virus type 1
and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71:
41–54.
31. Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, et al.
(1998) Trends of HIV-1 and sexually transmitted diseases among pregnant and
postpartum women in urban Malawi. AIDS 12: 197–203.
32. Mwapasa V, Rogerson SJ, Kwiek JJ, Wilson PE, Milner D, et al. (2006)
Maternal syphilis infection is associated with increased risk of mother-to-child
transmission of HIV in Malawi. AIDS 20: 1869–1877.
33. Nebie I, Tiono AB, Diallo DA, Samandoulougou S, Diarra A, et al. (2008) Do
antibody responses to malaria vaccine candidates influenced by the level of
malaria transmission protect from malaria? Tropical Medicine & International
Health 13: 229–237.
34. Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, et al. (1997)
Relation between severe malaria morbidity in children and level of Plasmodium
falciparum transmission in Africa. Lancet 349: 1650–1654.
35. Mwapasa V, Rogerson SJ, Molyneux ME, Abrams ET, Kamwendo DD, et al.
(2004) The effect of Plasmodium falciparum malaria on peripheral and placental
HIV-1 RNA concentrations in pregnant Malawian women. AIDS 18:
1051–1059.
36. Kwiek JJ, Mwapasa V, Alker AP, Muula AS, Misiri HE, et al. (2008) Socio-
demographic characteristics associated with HIV and syphilis seroreactivity
among pregnant women in Blantyre, Malawi, 2000-2004. Malawi Med J 20:
80–85.
37. Rowe AK, Kachur SP, Yoon SS, Lynch M, Slutsker L, et al. (2009) Caution is
required when using health facility-based data to evaluate the health impact of
malaria control efforts in Africa. Malar J 8: 209.
38. Okiro EA, Alegana VA, Noor AM, Mutheu JJ, Juma E, et al. (2009) Malaria
paediatric hospitalization between 1999 and 2008 across Kenya. BMC Med
7: 75.
Prevention against Malaria
PLoS ONE | www.plosone.org 9 August 2010 | Volume 5 | Issue 8 | e12012